Skip to content

Simultaneous EEG and fNIRS Assessment of Catatonia

Neurovascular Coupling Mechanisms and Brain Network Characteristics of the Catatonia Phenotype in Schizophrenia: An Exploratory Study Based on Simultaneous EEG-fNIRS Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115860
Enrollment
Unknown
Registered
2025-12-31
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Catatonia

Interventions

Catatonia-SCZ Group:N/A
Non-Catatonia-SCZ Group:N/A

Sponsors

Hangzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18–60 years (including 18 and 60), any gender, right-handed; 2. Meets the DSM-5 diagnostic criteria for schizophrenia, confirmed by at least two associate chief psychiatrists; 3. Capable of undergoing EEG-fNIRS brain functional imaging (normal or corrected-to-normal vision and hearing, no severe motor disorders); 4. Catatonia group (Catatonia-SCZ): must meet DSM-5 Criterion A for catatonia at enrollment (i.e., at least 3 of the 12 catatonia symptoms); 5. Non-catatonia group (Non-Catatonia-SCZ): while meeting the diagnostic criteria for schizophrenia, does not meet the DSM-5 criteria for catatonia at enrollment.

Exclusion criteria

Exclusion criteria: 1. Comorbid severe neurological diseases (such as epilepsy, stroke, brain tumors, etc.); 2. Comorbid severe somatic diseases (such as heart failure, renal failure, liver cirrhosis, active pulmonary tuberculosis, etc.) or unstable vital signs; 3. Clear substance dependence (including but not limited to alcohol) or recent history of substance abuse; 4. Contraindications for EEG or fNIRS examinations (such as severe scalp inflammation, skull defects, etc.); 5. Inability to cooperate with the research procedures (such as severe agitation, language comprehension disorders, etc.); 6. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
EEGG-fNIRS indicators;

Countries

China

Contacts

Public ContactYichao Wang

Hangzhou Seventh People's Hospital

peterpnn@163.com+86 571 8512 6516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026